Home/ Supplements/ Niacin/ NitroVarin

NitroVarin

product on market Liquid Novex Biotech Safety: 70/100
70/100

Review before taking

  • Niacin: 45mg is 1.3× the Tolerable Upper Intake Level (35mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 50% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Niacin is supported by strong evidence for improving lipid profiles and cardiovascular health. However, the remaining ingredients are listed in a proprietary blend, providing limited evidence regarding their specific efficacy and dosages. The overall evidence coverage for this formulation is very low.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 45mg is 1.3× the Tolerable Upper Intake Level (35mg)

Contains proprietary blend — exact ingredient amounts not disclosed

AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product contains more niacin than the recommended daily upper limit and uses a proprietary blend that hides the exact amounts of certain ingredients.

Label

Product Label

Label for NitroVarin
Open Full PDF View on NIH DSLD →
Details

Label Data

1 mL
Serving Size
30
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mg (225% DV)
Exceeds UL by 1.3× (UL: 35 mg) 196 studies (A:5, B:63)
Proprietary Blend containing
261 mg

Other Ingredients

Water Glycerin Sorbitol Sucralose Natural Flavors and Artificial Flavors Lactic Acid Sorbic Acid Sodium Benzoate Xanthan Gum
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Adults take one dropperful (1 mL) by mouth twice daily before meals. Do not exceed 2 servings per day. Shake well before use. Refrigerate after opening.

Warnings & Precautions

Keep out of reach of children.

Not for use by individuals under the age of 18 years. Do not use if pregnant or nursing.

Consult your physician before use if you are sensitive to stimulants.

Do not purchase if seal is broken.

Niacin (vitamin B3) may cause temporary skin flushing, redness or itching in those persons who are sensitive to niacin. If they occur, these temporary side effects will subside in a matter of minutes. Do not exceed suggested daily serving.

NOTE: Limit the use of caffeine-containing medications, foods or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness and occasionally, rapid heart beat. For additional information on this product, please call our experienced customer service representatives at: 1-800-898-5153.

WARNING: This product contains a significantly potent xanthine (i.e., caffeine and caffeine-like stimulants) mixture, of about 100 mg per serving.

Additional Information

Protect from heat, light, and moisture. Store at controlled room temperature: 15°-30°C/59°-86°F

††In a published, randomized, double-blind, placebo-controlled clinical study, 48 obese and overweight participants were divided into 2 groups, and were told to take either the active compound or a placebo before 2 main meals, with an 8-ounce glass of water. No major dietary changes nor exercise were suggested during the study. During the 10-week study, the group that took the active compound showed an average of 14.6% body fat lost and an average of 19.4 pounds lost without any major changes in diet or exercise. However, it is always advisable to engage in a sensible diet and exercise program.

©2011 All Rights Reserved

Active compound shown to influence the cellular dynamics of adipose (fat) cell metabolism.*

Advanced Liquid Fat Burning* Drops

BR13740-3

Clinically shown to significantly decrease body fat by an average of 14.6% in a matter of weeks*††

DSG-072806-213

Fat Burning* Energy*

If you or your health care provider have any questions, please call: 1-800-898-5153.

Individual results may vary.

International distribution is not authorized without prior written consent. Product resale allowed only through authorized representatives.

This product is manufactured to be within all acceptable industry variances.

Use in conjunction with any sensible diet and weight loss program.

Use only as directed.

Metadata

Product Details

UPC / SKU8 56528 00118 6
DSLD Entry Date2011-11-25
Product TypeOther Combinations
FormLiquid
DSLD ID2121
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.